# LBL-2016 for Children or Adolescents in China

> **NCT02845882** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Cancer Group, China** · enrollment: 150 (estimated)

## Conditions studied

- Lymphoblastic Lymphoma

## Interventions

- **DRUG:** Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
- **DRUG:** 6-mercaptopurine,Methotrexate
- **DRUG:** Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Doxorubicin, 6-mercaptopurine
- **DRUG:** Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Methotrexate
- **DRUG:** Dexamethasone, Vindesine, Methotrexate, Ifosfamide, Daunorubicin, Pegylated-asparaginase
- **DRUG:** Dexamethasone, Cytarabine, Etoposide, Pegylated-asparaginase
- **DRUG:** Methotrexate, 6-mercaptopurine

## Key facts

- **NCT ID:** NCT02845882
- **Lead sponsor:** Children's Cancer Group, China
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2031-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845882, "LBL-2016 for Children or Adolescents in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02845882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*